Alembic Limited has informed the Exchange regarding Outcome of Board Meeting held on May 13, 2025.
ALEMBICLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts more than Nifty Microcap 250 and 0.8 pts more than its Residential Commercial Projects peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Alembic Limited's board approved audited consolidated and standalone results for Q4 and FY ended March 31, 2025. Consolidated revenue from operations jumped to Rs. 22,189 lakhs in FY25 from Rs. 15,749 lakhs in FY24, a growth of about 41%, driven largely by the Real Estate segment (Rs. 18,967 lakhs vs Rs. 12,574 lakhs). Consolidated net profit (after share of associate Alembic Pharmaceuticals) rose to Rs. 31,068 lakhs from Rs. 26,862 lakhs, while standalone net profit surged to Rs. 14,195 lakhs from Rs. 9,289 lakhs, a jump of nearly 53%. Standalone EPS improved to Rs. 5.53 from Rs. 3.62. The board recommended a dividend of Rs. 2.40 per share (120%) on a Rs. 2 face value, unchanged from the previous year. The auditors CNK & Associates LLP issued an unmodified opinion on both sets of results, but included an emphasis of matter on a disputed electricity duty liability (Rs. 2,052 lakhs provisioned, Rs. 3,500 lakhs deposited with the Supreme Court).
Strong revenue and profit growth, especially in real estate, and a maintained 120% dividend are positive for shareholders. However, the ongoing electricity duty dispute remains a legal overhang, even though the auditor's opinion is clean.